✦ LIBER ✦

Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients

✍ Scribed by M.M Abou-Jaoude; I Ghantous; R Najm; C Afif; W.Y Almawi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of daclizumab, an interleukin

✍ Maroun M. Abou-Jaoude; Imad Ghantous; Wassim Y. Almawi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Intraoperative anti-thymocyte globulin-f

✍ Maroun M. Abou-Jaoude; Wassim Y. Almawi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Use of rabbit anti-thymocyte globulin fo

✍ P. Belitsky; A.S. MacDonald; J. Lawen; V. McAlister; H. Bitter-Suermann; B. Kibe 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Lower Risk of Infectious Deaths in Cardi

✍ Marie Françoise Mattei; Michel Redonnet; Iradj Gandjbakhch; Annick Mouly Bandini 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Comparison of outcomes with low-dose ant

✍ Pedro W. Baron; Okechukwu N. Ojogho; Peter Yorgin; Shobha Sahney; Drew Cutler; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB